Lipocine Inc. Announces Presentation at H.C. Wainwright 2026 Investor Conference

What Happened Lipocine Inc. (LPCN) filed a Form 8‑K on September 10, 2026 announcing it will present at the H.C. Wainwright 28th Annual Global Investor Conference, scheduled for September 14–16, 2026 in New York City. The company furnished a related press release as Exhibit 99.1 to the 8‑K.

Key Details

• Filing date: September 10, 2026 (Form 8‑K, Item 8.01 Other Events).
• Event: H.C. Wainwright 28th Annual Global Investor Conference, September 14–16, 2026, New York, NY.
• Press release announcing the presentation is included as Exhibit 99.1 to the 8‑K.

Why It Matters This 8‑K formally notifies investors and the market of Lipocine’s scheduled investor presentation, giving shareholders and analysts a chance to hear updates directly from the company at the conference. Investors seeking more detail should review the furnished press release (Exhibit 99.1) or the conference materials for presentation time and content.